MUSTGROW BIOLOGICS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.03 CAD | -1.90% |
|
-1.90% | -20.16% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 280K 205K | Sales 2025 * | - | Capitalization | 53.19M 39.01M |
|---|---|---|---|---|---|
| Net income 2024 * | -5M -3.67M | Net income 2025 * | - | EV / Sales 2024 * | 190 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-
| Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.21% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.90% | ||
| 1 week | -1.90% | ||
| Current month | -1.90% | ||
| 1 month | +0.98% | ||
| 3 months | -26.43% | ||
| 6 months | -14.17% | ||
| Current year | -20.16% |
1 week
1.00
1.08
1 month
0.761.15
Current year
0.761.48
1 year
0.722.25
3 years
0.725.60
5 years
0.255.60
10 years
0.255.60
| Managers | Title | Age | Since |
|---|---|---|---|
Corey Giasson
CEO | Chief Executive Officer | 46 | 18-03-14 |
Todd Lahti
DFI | Director of Finance/CFO | 58 | 18-12-16 |
Colin Bletsky
COO | Chief Operating Officer | 49 | 18-03-14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Brad Munro
CHM | Chairman | 64 | 18-03-14 |
Corey Giasson
CEO | Chief Executive Officer | 46 | 18-03-14 |
Thomas Flow
BRD | Director/Board Member | 47 | 18-05-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 1.03 | -1.90% | 3,301 |
| 24-05-16 | 1.05 | +0.96% | 6,900 |
| 24-05-15 | 1.04 | +2.97% | 23,785 |
| 24-05-14 | 1.01 | -3.81% | 15,200 |
Delayed Quote Toronto S.E., May 17, 2024 at 11:05 am EDT
More quotes
MustGrow Biologics Corp. is a Canada-based agricultural biotechnology company focused on providing science-based biological solutions for high-value crops. The Company is engaged in developing organic biocontrol, soil amendment and bio fertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply. It focuses on the development and commercialization of natural biological technologies and products from mustard seed for sustainable agricultural markets. The Company is providing a natural, organic technology platform with the efficacy of synthetic chemicals that has potential application in multiple global markets. Its technology pipeline includes soil amendment & bio fertility, biocontrol, and postharvest biocontrol & food preservation. The Company is pursuing the adoption and use of its technology in the soil amendment and bio fertility markets.
Calendar
2024-05-22
- Q1 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.03
Average target price
-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -20.16% | 39.08M | |
| +41.79% | 54.04B | |
| -0.56% | 41.92B | |
| +49.62% | 41.96B | |
| -7.20% | 28.35B | |
| +12.59% | 26.35B | |
| -21.51% | 19B | |
| +6.92% | 13B | |
| +24.91% | 12.19B | |
| +29.60% | 12.28B |
- Stock Market
- Equities
- MGRO Stock
